Back to Obstetrics & Gynecology
Obstetrics & Gynecologyv2005Evidence-Based

Swede Score

Predicts colposcopically high-grade lesions (HGL) on histology in cervical cancer screening. This standardized colposcopy scoring system evaluates five key characteristics to guide clinical decision-making and treatment planning for cervical intraepithelial neoplasia.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Swede Score is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within obstetrics & gynecology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Swede Score = Aceto uptake points + Margins/surface points + Vessels points + Lesion size points + Iodine staining points (total 0-10 points)

Clinical Pearls & Practice Notes

  • Each parameter scored 0, 1, or 2 points for a total maximum score of 10
  • Score ≥8 has high specificity (90-100%) for high-grade lesions
  • Score ≥5 has high sensitivity (92-100%) for detecting high-grade lesions
  • Useful for 'see and treat' protocols in resource-limited settings
  • Helps standardize colposcopic evaluation and reduce inter-observer variability
  • Should be used in conjunction with cytology and HPV testing results
  • Particularly valuable for training novice colposcopists
  • Can guide decision between surveillance, biopsy, or immediate treatment

Evidence & Literature Citations

  1. Strander B, Andersson-Ellström A, Milsom I, Rådberg T, Ryd W. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study. Cancer. 2007 Dec 25;111(6):285-91. doi: 10.1002/cncr.23100.
  2. Bowring J, Strander B, Young M, Evans H, Walker P. The Swede score: evaluation of a scoring system designed to improve the predictive value of colposcopy. J Low Genit Tract Dis. 2010 Oct;14(4):301-5. doi: 10.1097/LGT.0b013e3181d77756.

Score Interpretation Ranges

Low Risk0 – 4 pts

Low suspicion for high-grade lesion

Intermediate Risk5 – 7 pts

Consider biopsy based on clinical suspicion

High Risk8 – 10 pts

Concerning for high-grade lesion

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.